Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.

Stopped Carisbamate partial onset seizures studies lacked consistent efficacy data so trials in this indication were terminated.

Conditions

• Epilepsy
• Seizures

Interventions

• DRUG: carisbamate
• DRUG: topiramate
• DRUG: levetiracetam

Sponsor

SK Life Science, Inc.